Sandrock spent 23 years at Biogen, where he was head of R&D and chief medical officer.
Zolgensma, originally approved by the FDA in 2019, is the world's most expensive medicine at $2.125 million per treatment.
Biden said the U.S. government had invoked the Defense Production Act to help equip two Merck plants to make the J&J vaccine.
Company chart and information is provided by TradingView based on 15-minute-delayed data.
Enerplus Corp produces and develops crude oil and natural gas assets in Canada and the United States. Majority of oil production is derived from the Williston and Waterfloods basins, with the Marcellus providing a significant portion of natural gas production. Enerplus acquires the right to use assets through royalties paid to government entities, land owners and mineral rights owners. Crude oil and natural gas are sold to customers in both countries where assets are held and can be sold either at the well or a fixed destination.
| Website: | www.enerplus.com |
| Email: | investorrelations@enerplus.com |
| Main Phone: | +1 403 298-2200 |
| Address: | 3000, 333 - 7th Avenue S.W. |
| Address 2: | The Dome Tower |
| State: | AB |
| City / Town: | Calgary |
| Country: | CA |
| Postal Code: | T2P 2Z1 |
| Exchange: | NYE |
| CEO: | Ian C. Dundas |
| Employees: | 360 |
| NAICS: | Crude Petroleum Extraction(211120) |
Sandrock spent 23 years at Biogen, where he was head of R&D and chief medical officer.
Zolgensma, originally approved by the FDA in 2019, is the world's most expensive medicine at $2.125 million per treatment.
Biden said the U.S. government had invoked the Defense Production Act to help equip two Merck plants to make the J&J vaccine.
Unlike green bonds which are linked to specific environmental projects, sustainability-linked bonds are tied to whole corporate goals.
Ofatumumab was approved by the FDA in 2009 for chronic lymphocytic leukaemia (CLL). It will be marketed as Kesimpta for multiple sclerosis.
90% of all prescriptions involve generics, medications that no longer hold patent protetection.
CEO Vas Narasimhan said the "extremely disruptive environment" of the pandemic would lead to mid-single digit percentage revenue growth for the full year, down from previous expectations of mid-to-high single-digit growth.
Novartis said it would provide medicines ranging from antibiotics and steroids to diarrhea pills to 79 countries on the World Bank’s list of low- and lower-middle income nations.
The moves further dampen hopes for a treatment that has been consistently and loudly touted by Trump as a gamechanger.
Artificial intelligence points to a rheumatoid arthritis drug that may be a viable treatment for the new virus.
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
© 2022 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
